Jin Long Chen
Directeur/Bestuurslid bij TENAYA THERAPEUTICS, INC.
Vermogen: 2 M $ op 31-05-2024
Actieve functies van Jin Long Chen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TENAYA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-10-2016 | - |
| Independent Dir/Board Member | 01-10-2016 | - |
Loopbaan van Jin Long Chen
Eerdere bekende functies van Jin Long Chen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-01-2008 | 04-04-2023 |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2008 | 04-04-2023 | |
| Oprichter | 20-12-2007 | 04-04-2023 | |
| President | 01-01-2008 | 01-11-2014 | |
| AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 | 01-01-2008 |
| Corporate Officer/Principal | - | 01-01-2008 | |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Opleiding van Jin Long Chen
| Fu Jen Catholic University | Undergraduate Degree |
| National Taiwan University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Taiwan | 3 |
Operationeel
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
- Beurs
- Insiders
- Jin Long Chen
- Ervaring
